Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Operating Cash Flow Growth Under PressureDecelerating
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year operating cash flow growth rate

Latest
0.00%
↓ 100% vs avg
Percentile
P33
Within normal range
Streak
2 yr
Consecutive declineDecelerating
Average
6.16%
Historical baseline
PeriodValue
20250.00%
202493.14%
2023129.05%
2022104.60%
20217.50%
202013.79%
2019-95.49%
2018-61.32%
2017-129.66%
20160.00%